Treatment recommendations are based on provider evaluation
The committees recommendations are advisory, and no final FDA action adding these substances to the 503A Bulks List has yet occurred." The views expressed here in quoted statements are the individuals' personal opinions and do not constitute medical advice, nor do they represent the views or positions of any current or past employer or affiliated institution
10.1016/j.scitotenv.2019.135931 106 ZhangT.JiangB.XingY.YaH.LvM.WangX
We found that, regardless of the total dose of rHuEPO used, this substance improves the main hematological (total hemoglobin mass, hemoglobin concentration, and hematocrit) and physiological (maximal oxygen uptake and peak oxygen uptake) parameters, while the maximal performance-related parameters (mainly, maximal power output, and peak power output) also tend to increase
The optimal choice depends on whether the focus is hypertrophy signaling or recovery enhancement